换一批
换一批A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function.
作者：
主题词
抗体, 单克隆(Antibodies, Monoclonal);环孢菌素(Cyclosporine);移植物功能延迟恢复(Delayed Graft Function);药物疗法, 联合(Drug Therapy, Combination);女(雌)性(Female);移植物排斥(Graft Rejection);移植物存活(Graft Survival);人类(Humans);免疫抑制剂(Immunosuppressive Agents);肾功能试验(Kidney Function Tests);肾移植(Kidney Transplantation);男(雄)性(Male);中年人(Middle Aged);霉酚酸(Mycophenolic Acid);前瞻性研究(Prospective Studies);重组融合蛋白质类(Recombinant Fusion Proteins);危险因素(Risk Factors);存活率(Survival Rate);治疗结果(Treatment Outcome)
DOI
10.1111/j.1399-0012.2008.00891.x
PMID
18798851
发布时间
2018-12-01
- 浏览4
Clinical transplantation
23-32页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
